312 related articles for article (PubMed ID: 27626314)
1. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
3. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
4. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein.
Zheng X; Wang X; Tu F; Wang Q; Fan Z; Gao G
J Virol; 2017 May; 91(9):. PubMed ID: 28202764
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.
Lee JM; Choi SS; Lee YH; Khim KW; Yoon S; Kim BG; Nam D; Suh PG; Myung K; Choi JH
Exp Mol Med; 2018 Oct; 50(10):1-11. PubMed ID: 30323259
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells.
Li YH; Zhong M; Zang HL; Tian XF
Exp Cell Res; 2018 Oct; 371(1):250-254. PubMed ID: 30118695
[TBL] [Abstract][Full Text] [Related]
7. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
9. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
[TBL] [Abstract][Full Text] [Related]
10. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases.
Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG
PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640
[TBL] [Abstract][Full Text] [Related]
12. TRIM25 Binds RNA to Modulate Cellular Anti-viral Defense.
Sanchez JG; Sparrer KMJ; Chiang C; Reis RA; Chiang JJ; Zurenski MA; Wan Y; Gack MU; Pornillos O
J Mol Biol; 2018 Dec; 430(24):5280-5293. PubMed ID: 30342007
[TBL] [Abstract][Full Text] [Related]
13. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation.
Meyerson NR; Zhou L; Guo YR; Zhao C; Tao YJ; Krug RM; Sawyer SL
Cell Host Microbe; 2017 Nov; 22(5):627-638.e7. PubMed ID: 29107643
[TBL] [Abstract][Full Text] [Related]
14. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
[TBL] [Abstract][Full Text] [Related]
15. TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP).
Li MM; Lau Z; Cheung P; Aguilar EG; Schneider WM; Bozzacco L; Molina H; Buehler E; Takaoka A; Rice CM; Felsenfeld DP; MacDonald MR
PLoS Pathog; 2017 Jan; 13(1):e1006145. PubMed ID: 28060952
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
17. Delineation of TMPRSS2-ERG splice variants in prostate cancer.
Hu Y; Dobi A; Sreenath T; Cook C; Tadase AY; Ravindranath L; Cullen J; Furusato B; Chen Y; Thangapazham RL; Mohamed A; Sun C; Sesterhenn IA; McLeod DG; Petrovics G; Srivastava S
Clin Cancer Res; 2008 Aug; 14(15):4719-25. PubMed ID: 18676740
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.
Choudhury NR; Heikel G; Trubitsyna M; Kubik P; Nowak JS; Webb S; Granneman S; Spanos C; Rappsilber J; Castello A; Michlewski G
BMC Biol; 2017 Nov; 15(1):105. PubMed ID: 29117863
[TBL] [Abstract][Full Text] [Related]
19. Positive regulatory role of c-Src-mediated TRIM25 tyrosine phosphorylation on RIG-I ubiquitination and RIG-I-mediated antiviral signaling pathway.
Lee NR; Choi JY; Yoon IH; Lee JK; Inn KS
Cell Immunol; 2018 Oct; 332():94-100. PubMed ID: 30100205
[TBL] [Abstract][Full Text] [Related]
20. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
Wang S; Kollipara RK; Srivastava N; Li R; Ravindranathan P; Hernandez E; Freeman E; Humphries CG; Kapur P; Lotan Y; Fazli L; Gleave ME; Plymate SR; Raj GV; Hsieh JT; Kittler R
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4251-6. PubMed ID: 24591637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
